Hologic logo, dark blue
Hologic logo, dark blue

Transplant Solution

Reimagine your transplant workflow by consolidating your complete test menu on one single high throughput platform.

Get in Touch
Lab technician putting test tubes into equipment

Simplify the Future of Transplant Testing

An innovative solution designed to expand your transplant capabilities and simplify, standardise and accelerate testing, now and into the future. Every moment matters when it comes to protecting immunocompromised patients.

Advanced Automation

Integrate and consolidate your transplant, viral load, respiratory, STI and women’s health testing on a single, fully automated high throughput system, unlocking flexibility and operational efficiency.1

Precision & Flexibility

The high performing Aptima CMV Quant assay is clinically validated for whole blood and plasma on the fully automated, high throughout Panther® System, giving labs the versatility and precision to detect, diagnose and deliver results.2   

Confidence & Control

The launch of CE-IVD approved Panther® Fusion EBV Quant and BKV Quant Assays continues our promise of innovation across critical post-transplant monitoring.3,4

Work with Different Testing Matrices at the Same Time

The entire transplant portfolio can be run in conjunction with other viral assays, ensuring streamlined laboratory workflows. Future-proof your diagnostic infrastructure to drive performance and meet the increased need for transplant testing.

5 yrs

transplant testing have increased in Europe over the last 5 years5

59%

of labs across Europe use two or more transplant testing platforms6

79%

are interested in consolidating transplant tests on one platform7

One Solution. Infinite possibilities

Hologic’s Molecular Scalable Solutions now has a fully automated Transplant Solution, combining a large CE-IVD assay portfolio with advanced automation.

image of Aptima® CMV Quant Assay box on white background

Aptima® CMV Quant Assay

Cytomegalovirus (CMV) infection is a common complication that affects organ transplant patients. A highly sensitive CMV Quant assay deliver actionable viral load insights to post-transplant patients and their care teams.2

image of Panther Fusion® BKV Quant Assay box on white background

Panther Fusion® BKV Quant Assay

The BKV Quant assay is used for the quantification of post-transplant infections. This assay runs on Panther Fusion and leverages polymerase chain reaction (RT-PCR) technology.3

image of assay box on white background

Panther Fusion® EBV Quant Assay

The EBV Quant assay is used for the quantification of post-transplant infections. This assay runs on Panther Fusion and leverages polymerase chain reaction (RT-PCR) technology.4

Image of Panther® Scalable Solution on white background

Panther® Scalable Solution

The Hologic high-throughput solution allows you to expand your testing menu while adding on flexibility, capacity and walkaway time. The Panther® System is the foundation of Panther Scalable Solutions. It lets you customise your testing by choosing from a broad assay menu and instrument add-ons, allowing an economical and scalable path to your growth.

Load more

Get Support

All Other Requests

Insights

Visit the Hologic Innovation Exchange

Simplify & Scale the Future of Diagnostics

The Transplant Solution is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient rapid result to population level screening.

Browse Portfolio
Technician walking by Panther Systems in a lab setting
    References
    1. Panther/Panther Fusion System Operator´s Manual. AW-26055-001 Rev 001, San Diego, CA: Hologic Inc.; 2022.
    2. Aptima CMV Quant Assay [package insert]. AW-25509-001 Rev 003, San Diego, CA: Hologic, Inc.; 2022.     
    3. Panther Fusion BKV Quant Assay [package insert]. AW-26020-001 Rev 001, San Diego, CA: Hologic, Inc.; 2022        
    4. Panther Fusion EBV Quant Assay [package insert]. AW-26019-001 Rev 002, San Diego, CA: Hologic, Inc.; 2023
    5. Transplant Panel Market Research, final presentation, May 6th, 2021, page 19
    6. Transplant Panel Market Research, final presentation, May 6th, 2021, page 22
    7. Transplant Panel Market Research, final presentation, May 6th, 2021, page 46

    Related Portfolios & Solutions

    Placeholder image
    Portfolio

    Cervical Health

    Global leaders in population screening, advancing the early detection of cervical cancer.

    Solution

    High-Throughput Testing

    Solution

    On-Demand Testing

    Solution

    HPV

    Solution

    Respiratory

    Solution

    STI

    Solution

    Virology

    Solution

    Vaginal health

    Solution

    Hospital Acquired Infections

    Solution

    Gastrointestinal

    Solution

    Antimicrobial Resistance

    Solution

    Collection Devices

    Solution

    Lab Developed Tests

    1434

    Hologic BV, DA Vincilaan 5, 1930 Zaventem, Belgium

    Notified Body number wherever applicable
    EC Representative Information wherever applicable